Value proposition

We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases

Vandria is a biopharmaceutical company that develops best-in-class small molecule mitophagy inducers to treat age-related and chronic diseases in the fields of Muscle- and CNS diseases with large unmet medical need.